Rapidemic Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 12

Rapidemic General Information

Description

Developer of molecular point-of-care test kits intended to diagnose infectious diseases on the spot. The company's kits utilize a primer technology to detect new airborne infectious diseases and speed up the testing of roaming viruses, enabling clinicians to test infected people anywhere without a laboratory and limited medical facilities and get the results within an hour after the test has been taken.

Contact Information

Website
www.rapidemic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • BioPartner 3
  • Gallileiweg 8
  • 2333 BD Leiden
  • Netherlands
+31 0474
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Medical Supplies
Vertical(s)
LOHAS & Wellness, Digital Health, HealthTech
Corporate Office
  • BioPartner 3
  • Gallileiweg 8
  • 2333 BD Leiden
  • Netherlands
+31 0474

Rapidemic Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rapidemic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
10. Grant 25-Sep-2025 Completed Generating Revenue
9. Early Stage VC 31-Oct-2024 Completed Generating Revenue
8. Accelerator/Incubator 07-Feb-2024 Completed Generating Revenue
7. Accelerator/Incubator 01-Aug-2023 Completed Generating Revenue
6. Grant 30-Sep-2022 Completed Generating Revenue
5. Grant 01-Jan-2022 Completed Generating Revenue
4. Seed Round 13-Dec-2021 Completed Generating Revenue
3. Grant 01-Jan-2021 $10K Completed Startup
2. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Rapidemic’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Rapidemic Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Rapidemic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4590853-A1 Methods and device for multiple-label nucleic acid amplification and detection Pending 23-Sep-2022
US-20260357329-A1 Methods and device for multiple-label nucleic acid amplification and detection Pending 23-Sep-2022
WO-2024063653-A1 Methods and device for multiple-label nucleic acid amplification and detection Inactive 23-Sep-2022 C12Q1/6844

Rapidemic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rapidemic Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
Gates Foundation Not-For-Profit Venture Capital Minority
unlock_ Accelerator/Incubator
BioInnovation Institute Accelerator/Incubator
Province Holland Zuid Government
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Rapidemic FAQs

  • When was Rapidemic founded?

    Rapidemic was founded in 2020.

  • Where is Rapidemic headquartered?

    Rapidemic is headquartered in Leiden, Netherlands.

  • What is the size of Rapidemic?

    Rapidemic has 12 total employees.

  • What industry is Rapidemic in?

    Rapidemic’s primary industry is Diagnostic Equipment.

  • Is Rapidemic a private or public company?

    Rapidemic is a Private company.

  • What is Rapidemic’s current revenue?

    The current revenue for Rapidemic is .

  • How much funding has Rapidemic raised over time?

    Rapidemic has raised $638K.

  • Who are Rapidemic’s investors?

    Nordic Mentor Network For Entrepreneurship, Gates Foundation, unlock_, BioInnovation Institute, and Province Holland Zuid are 5 of 12 investors who have invested in Rapidemic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process